{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:52:14Z","timestamp":1759179134164,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hannah's Hope Fund"},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS087175","NS095515"],"award-info":[{"award-number":["NS087175","NS095515"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD040127","U54HD079124"],"award-info":[{"award-number":["HD040127","U54HD079124"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-018-0957-5","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T14:03:15Z","timestamp":1549029795000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens"],"prefix":"10.1186","volume":"14","author":[{"given":"Diane","family":"Armao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Bouldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody E.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana X.","family":"Bharucha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"issue":"4","key":"957_CR1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mus.24321","volume":"50","author":"BL Johnson-Kerner","year":"2014","unstructured":"Johnson-Kerner BL, Roth L, Greene JP, Wichterle H, Sproule DM. Giant axonal neuropathy: an updated perspective on its pathology and pathogenesis. Muscle Nerve. 2014;50(4):467\u201376.","journal-title":"Muscle Nerve"},{"issue":"25","key":"957_CR2","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1091\/mbc.e16-06-0362","volume":"27","author":"NH Lin","year":"2016","unstructured":"Lin NH, Huang YS, Opal P, Goldman RD, Messing A, Perng MD. The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Mol Biol Cell. 2016;27(25):3980\u201390.","journal-title":"Mol Biol Cell"},{"key":"957_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rsif.2017.0123","volume":"14","author":"A Soomro","year":"2017","unstructured":"Soomro A, Alsop RJ, Negishi A, Kreplak DF, Kuczmarski ER, Goldman RD, Rheinstadter MC. Giant axonal neuropathy alters the structure of keratin intermediate fialments in human hair. JR Soc Interface. 2017;14:1\u20139.","journal-title":"JR Soc Interface"},{"issue":"9","key":"957_CR4","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1093\/hmg\/ddl069","volume":"15","author":"J Ding","year":"2006","unstructured":"Ding J, Allen E, Wang W, Valle A, Wu C, Nardine T, et al. Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport. Hum Mol Genet. 2006;15(9):1451\u201363.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"957_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1750-1326-6-25","volume":"6","author":"T Ganay","year":"2011","unstructured":"Ganay T, Boizot A, Burrer R, Chauvin JP, Bomont P. Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice. Mol Neurodegener. 2011;6(1):25.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"957_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1471-4159.2008.05601.x","volume":"107","author":"F Dequen","year":"2008","unstructured":"Dequen F, Bomont P, Gowing G, Cleveland DW, Julien J-P. Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J Neurochem. 2008;107(1):253\u201364.","journal-title":"J Neurochem"},{"issue":"4","key":"957_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10286-016-0365-7","volume":"26","author":"D Armao","year":"2016","unstructured":"Armao D, Bailey RM, Bouldin TW, Kim Y, Gray SJ. Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease. Clin Auton Res. 2016;26(4):307\u201313.","journal-title":"Clin Auton Res"},{"key":"957_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.omtm.2018.02.005","volume":"9","author":"RM Bailey","year":"2018","unstructured":"Bailey RM, Armao D, Nagabhushan Kalburgi S, Gray SJ. Development of intrathecal AAV9 gene therapy for Giant axonal neuropathy. Mol Ther Methods Clin Dev. 2018;9:160\u201371.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"957_CR9","unstructured":"Intrathecal Administration of scAAV9\/JeT-GAN for the Treatment of Giant Axonal Neuropathy ClinicalTrials.gov [updated July 16, 2018. Available from: \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02362438\n                    \n                  ."},{"issue":"7","key":"957_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1172\/JCI38277","volume":"119","author":"S Song","year":"2009","unstructured":"Song S, Landsbury A, Dahm R, Liu Y, Zhang Q, Quinlan RA. Functions of the intermediate filament cytoskeleton in the eye lens. J Clin Invest. 2009;119(7):1837\u201348.","journal-title":"J Clin Invest"},{"issue":"5","key":"957_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/exer.2000.0835","volume":"70","author":"NS Wolf","year":"2000","unstructured":"Wolf NS, Li Y, Pendergrass W, Schmeider C, Turturro A. Normal mouse and rat strains as models for age-related cataract and the effect of caloric restriction on its development. Exp Eye Res. 2000;70(5):683\u201392.","journal-title":"Exp Eye Res"},{"issue":"6","key":"957_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1177\/0883073814542946","volume":"30","author":"LA Roth","year":"2015","unstructured":"Roth LA, Marra JD, LaMarca NH, Sproule DM. Measuring disease progression in giant axonal neuropathy: implications for clinical trial design. J Child Neurol. 2015;30(6):741\u20138.","journal-title":"J Child Neurol"},{"issue":"3","key":"957_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/088307389000500316","volume":"5","author":"K Kumar","year":"1990","unstructured":"Kumar K, Barre P, Nigro M, Jones MZ. Giant axonal neuropathy: clinical, electrophysiologic, and neuropathologic features in two siblings. J Child Neurol. 1990;5(3):229\u201334.","journal-title":"J Child Neurol"},{"issue":"2","key":"957_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/BF00693779","volume":"73","author":"HA Kretzschmar","year":"1987","unstructured":"Kretzschmar HA, Berg BO, Davis RL. Giant axonal neuropathy. A neuropathological study. Acta Neuropathol. 1987;73(2):138\u201344.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"957_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00691956","volume":"40","author":"J Peiffer","year":"1977","unstructured":"Peiffer J, Schlote W, Bischoff A, Boltshauser E, Muller G. Generalized giant axonal neuropathy: a filament-forming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta Neuropathol. 1977;40(3):213\u20138.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"957_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.410220118","volume":"22","author":"C Thomas","year":"1987","unstructured":"Thomas C, Love S, Powell HC, Schultz P, Lampert PW. Giant axonal neuropathy: correlation of clinical findings with postmortem neuropathology. Ann Neurol. 1987;22(1):79\u201384.","journal-title":"Ann Neurol"},{"key":"957_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-4835(02)00278-6","volume":"76","author":"J Horwitz","year":"2003","unstructured":"Horwitz J. Alpha-crystallin. Exp Eye Res. 2003;76:145\u201353.","journal-title":"Exp Eye Res"},{"issue":"7","key":"957_CR18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/hmg\/ddp013","volume":"18","author":"TL Hagemann","year":"2009","unstructured":"Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Supression of GFAP toxicity by alpha B-crystallin in mouse models of Alexander disease. Hum Mol Genet. 2009;18(7):1190\u20139.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"957_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1874467211003030164","volume":"3","author":"H Varma","year":"2010","unstructured":"Varma H. Drug screening for Huntington's disease and other neurodegenerative disorders. Curr Mol Pharmacol. 2010;3(3):164\u201373.","journal-title":"Curr Mol Pharmacol"},{"issue":"9","key":"957_CR20","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/ajmg.a.38326","volume":"173","author":"W Sun","year":"2017","unstructured":"Sun W, Zheng W, Simeonov A. Drug discovery and development for rare genetic disorders. Am J Med Genet A. 2017;173(9):2307\u201322.","journal-title":"Am J Med Genet A"},{"issue":"12","key":"957_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.biocel.2010.09.012","volume":"42","author":"G Martinez","year":"2010","unstructured":"Martinez G, de Iongh RU. The lens epithelium in ocular health and disease. Int J Biochem Cell Biol. 2010;42(12):1945\u201363.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"957_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrm3753","volume":"15","author":"NT Snider","year":"2014","unstructured":"Snider NT, Omary MB. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat Rev Mol Cell Biol. 2014;15(3):163\u201377.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0957-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0957-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T10:34:48Z","timestamp":1589538888000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0957-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["957"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0957-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were performed in accordance with the Guide for the Care and Use of Laboratory Animals [DHHS Publication No. (NIH) 85\u201323] and approved by the UNC\u2013CH Institutional Animal Care and Use Committee. Human specimens were obtained through a validated autopsy consent from the legal next of kin, which explicitly stated that tissues could be used for research purposes. The consent and diagnostic autopsy report were filed in the deceased patient\u2019s medical record.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"27"}}